Drug intelligence / Profile preview

2'-deoxy-2'-fluoroadenosine

Development stage
Preclinical
Lead developer
Southern Research
Modality
Small Molecules
Administration
Intravenous
01

Overview

2'-Deoxy-2'-fluoroadenosine is a modified nucleoside analog and small molecule antimetabolite characterized by the substitution of a fluorine atom at the 2' position of the ribose sugar. It functions as a prodrug in suicide gene therapy systems, where it is selectively cleaved by *Escherichia coli* purine nucleoside phosphorylase (PNP) to release the highly cytotoxic agent 2-fluoroadenine. This metabolite inhibits DNA and RNA synthesis, leading to cell death in both proliferating and quiescent cells, a property utilized to treat solid tumors expressing the bacterial PNP gene. Beyond oncology, the compound and its derivatives have been investigated for antiviral activity against a range of RNA and DNA viruses, including Hepatitis C virus (HCV), HIV, SARS-CoV, and influenza, often acting as a viral polymerase inhibitor or chain terminator. It is also widely employed as a research tool in the synthesis of modified oligonucleotides to investigate nucleic acid structure and protein-nucleic acid interactions.

Other names
2'-Fluoro-2'-deoxyadenosine9-(2-deoxy-2-fluoro-beta-D-ribofuranosyl)adenine
02

Targets

PNP (Purine nucleoside phosphorylase)

Beyond the preview

Go deeper on 2'-deoxy-2'-fluoroadenosine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2'-deoxy-2'-fluoroadenosine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call